Potassium Hydroxide → 2-(4-Cyanopiperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline
反応式
[NH2:1][C:2]1[C:11]2[C:6](=[CH:7][C:8]([O:14][CH3:15])=[C:9]([O:12][CH3:13])[CH:10]=2)[N:5]=[C:4](Br)[N:3]=1.[C:17]([N:19]1[CH2:24][CH2:23][NH:22][CH2:21][CH2:20]1)#[N:18].[OH-].[K+]>>[C:17]([N:19]1[CH2:24][CH2:23][N:22]([C:4]2[N:3]=[C:2]([NH2:1])[C:11]3[C:6](=[CH:7][C:8]([O:14][CH3:15])=[C:9]([O:12][CH3:13])[CH:10]=3)[N:5]=2)[CH2:21][CH2:20]1)#[N:18]参加物
4
実験手順
In a flask fitted with stirrer, thermometer, and drying tube is placed 100 ml. of chloroform, 12.0 g. (0.05 mole) of 4-amino-2-bromo-6,7-dimethoxyquinazoline (prepared by the method of U.S. Pat. No. 3,511,836) and 5.8 g. (0.052 mole) of 1-cyanopiperazine. The mixture is maintained at 50° C. for 24 hours after which 2N potassium hydroxide solution is added at room temperature to adjust to pH 9.5. The organic layer is separated and the aqueous phase extracted again with chloroform and the combined extracts are evaporated to dryness to obtain 2-(4-cyanopiperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline.
後処理
- customIn a flask fitted with stirrer
- customthermometer, and drying tube
- additionis added at room temperature
- customThe organic layer is separated
- extractionthe aqueous phase extracted again with chloroform
- customthe combined extracts are evaporated to dryness
出典と根拠
- ORDレコード
- ord-610d6ab3dd524579bd5a158c02a818e0
- 出典データセット
- uspto-grants-1977_12
- 特許番号
- US04062844
反応ノート
読み込み中…